Trendlines Group

The investments of DSM Venturing, Cibus Fund, and Ginkgo Bioworks open the door for broad penetration of our products in the global food industry We are excited to have new investors who share our vision to create healthy, efficient, and sustainable food systems via biotechnology

Halim Jubran PhD, Co-founder and CEO of Phytolon Closed $14 5 million Series A funding round Signed collaboration with Ginkgo Bioworks Selected as one of top 30 global start-ups at SLINGSHOT 2019, Singapore, November 2019 Vensica has developed minimally invasive solutions in urology, unlocking the unique properties of therapeutic ultrasound to deliver neurotoxins

Vensica’s journey from our establishment in 2014, through to our strategic partnership with Merz and the latest investment round, took many twists and turns Trendlines was there for us at each stage

Avner Geva, CEO Vensica Therapeutics Strategic license and collaboration agreement with Merz Therapeutics Full development of a needle-less delivery system utilizing the power of therapeutic ultrasound $19 million investment round led by Israeli VC IBF

How we do it

Our global team brings together science, technology, and business expertise to invest in and build innovation-based healthcare and agrifood companies

how we

connect with you liberDi receives FDA regulatory clearance for its digital dialysis system Potential to become the standard of care for home peritoneal dialysis The Edge and the SGX – 10 in 10 with Trendlines Collaborative study by NeuroQuest and AIBL shows specific biomarkers for Alzheimer’s could lead to blood-based screening tool

Keep up to date

By checking this you consent to the use of your data in accordance with our privacy policy

Misgav Business Park, 17 T’chelet Street M P Misgav, 2017400 Blk 77, Ayer Rajah Crescent, #02-21/26 Singapore, 139954